Selleck Chemicals supplies over 3,000 inhibitors used in the study of cell signaling pathways. We actively tracks the latest science so our customers can rely on us to be the leading supplier of the newest inhibitors.
Company WebsiteAnti-TSHR are unconjugated polyclonal antibodies derived from rabbi. Anti-TSHR are pathophysiologic, and also increases their significance in the diagnosis of autoimmune thyroid diseases and Graves’ disease.
More Information Supplier PageAnti-TSPAN26 / CD37 (AGS67E) is a fully human monoclonal antibody that targets CD37. It is used for the potential treatment of B/T-cell malignancies. MW :143.44 KD.
More Information Supplier PageAnti-TSPAN26 / CD37 (AGS67E) is a fully human monoclonal antibody that targets CD37. It is used for the potential treatment of B/T-cell malignancies. MW :143.44 KD.
More Information Supplier PageAnti-TSPAN26 / CD37 (AGS67E) is a fully human monoclonal antibody that targets CD37. It is used for the potential treatment of B/T-cell malignancies. MW :143.44 KD.
More Information Supplier PageAnti-TSPAN8 is a monoclonal IgG1 antibody (mAb) directed against Co-029, a membrane protein of the family of tetraspanins (TSPAN8 or TM4SF3). MW: 145.94 KD.
More Information Supplier PageAnti-TSPAN8 is a monoclonal IgG1 antibody (mAb) directed against Co-029, a membrane protein of the family of tetraspanins (TSPAN8 or TM4SF3). MW: 145.94 KD.
More Information Supplier PageAnti-TSPAN8 is a monoclonal IgG1 antibody (mAb) directed against Co-029, a membrane protein of the family of tetraspanins (TSPAN8 or TM4SF3). MW: 145.94 KD.
More Information Supplier PageAnti-TYRO3 (ELB031) is a monoclonal antibody that targets TYRO3 and MERTK.
More Information Supplier PageAnti-TYRO3 (ELB031) is a monoclonal antibody that targets TYRO3 and MERTK.
More Information Supplier PageAnti-TYRO3 (ELB031) is a monoclonal antibody that targets TYRO3 and MERTK.
More Information Supplier PageAnti-VCAM1 / CD106 is a conjugated liposome targeting vascular cell adhesion molecule (VCAM)-1. It serves as a drug delivery system with dual functions: targeted delivery and solubilizing capacity. MW :143.4 KD.
More Information Supplier PageAnti-VCAM1 / CD106 is a conjugated liposome targeting vascular cell adhesion molecule (VCAM)-1. It serves as a drug delivery system with dual functions: targeted delivery and solubilizing capacity. MW :143.4 KD.
More Information Supplier PageAnti-VCAM1 / CD106 is a conjugated liposome targeting vascular cell adhesion molecule (VCAM)-1. It serves as a drug delivery system with dual functions: targeted delivery and solubilizing capacity. MW :143.4 KD.
More Information Supplier PageAnti-VEGFC is a fully human monoclonal antibody targeting the human vascular endothelial growth factor C (VEGFC or Flt4 ligand) with potential antiangiogenic activity and lymphangiogenesis. It also prevent metastasis. MW :145.5 KD.
More Information Supplier PageAnti-VEGFC is a fully human monoclonal antibody targeting the human vascular endothelial growth factor C (VEGFC or Flt4 ligand) with potential antiangiogenic activity and lymphangiogenesis. It also prevent metastasis. MW :145.5 KD.
More Information Supplier PageAnti-VEGFC is a fully human monoclonal antibody targeting the human vascular endothelial growth factor C (VEGFC or Flt4 ligand) with potential antiangiogenic activity and lymphangiogenesis. It also prevent metastasis. MW :145.5 KD.
More Information Supplier PageAnti-VEGFR2 / KDR / CD309 (Imclone 6.64) is a monoclonal antibody targated against vascular endothelial growth factor receptor-2 (VEGFR2) with anti-angiogenesis and anti-tumour activity. MW: 145.4 KD.
More Information Supplier PageAnti-VEGFR2 / KDR / CD309 (Imclone 6.64) is a monoclonal antibody targated against vascular endothelial growth factor receptor-2 (VEGFR2) with anti-angiogenesis and anti-tumour activity. MW: 145.4 KD.
More Information Supplier PageAnti-VEGFR2 / KDR / CD309 (Imclone 6.64) is a monoclonal antibody targated against vascular endothelial growth factor receptor-2 (VEGFR2) with anti-angiogenesis and anti-tumour activity. MW: 145.4 KD.
More Information Supplier PageAnti-VEGFR3 / FLT4 is a fully-human monoclonal antibody directed against (VEGFR-3; Flt-4) with antiangiogenic activity.Anti-VEGFR3 / FLT4 also plays a critical role in the embryonic vascular system development.
More Information Supplier PageAnti-VEGFR3 / FLT4 is a fully-human monoclonal antibody directed against (VEGFR-3; Flt-4) with antiangiogenic activity.Anti-VEGFR3 / FLT4 also plays a critical role in the embryonic vascular system development.
More Information Supplier PageAnti-VEGFR3 / FLT4 is a fully-human monoclonal antibody directed against (VEGFR-3; Flt-4) with antiangiogenic activity.Anti-VEGFR3 / FLT4 also plays a critical role in the embryonic vascular system development.
More Information Supplier PageAnti-vWF is a monoclonal anti-VWF antibody with the potential to treat thrombotic thrombocytopenic purpura. MW: 145.62 KD.
More Information Supplier PageAnti-vWF is a monoclonal anti-VWF antibody with the potential to treat thrombotic thrombocytopenic purpura. MW: 145.62 KD.
More Information Supplier PageAnti-vWF is a monoclonal anti-VWF antibody with the potential to treat thrombotic thrombocytopenic purpura. MW: 145.62 KD.
More Information Supplier PageAntiarol (3,4,5-trimethoxyphenol) is a member of aromatic phenols and exhibits moderate DPPH free radical scavenging activity.
More Information Supplier PageA unique collection of 484 antibiotics used for anti- research in order to identify drug target and open up new mechanism and ways to treat human disease.
More Information Supplier PageAntide(Iturelix), a gonadotropin-releasing hormone (GNRH) antagonist, inhibits apoptosis of preovulatory follicle cells in the rat ovary.
More Information Supplier PageAntide(Iturelix), a gonadotropin-releasing hormone (GNRH) antagonist, inhibits apoptosis of preovulatory follicle cells in the rat ovary.
More Information Supplier PageAntimonyl potassium tartrate trihydrate (Tartar emetic) is a powerful emetic, also used in the treatment of schistosomiasis and leishmaniasis.This product is a hazardous chemical (acute toxicity/flammable/skin corrosive). Please use it while wearing a protective face mask, gloves, and clothing.
More Information Supplier PageAntineoplaston A10 is a naturally occurring substance in the human body that that can be potentially used for the treatment of glioma, lymphoma, astrocytoma and breast cancer. The main ingredient active of antineoplaston A10 (Phenylacetylglutamine, PG) inhibits RAS and promotes apoptosis.
More Information Supplier PageAntineoplaston A10 is a naturally occurring substance in the human body that that can be potentially used for the treatment of glioma, lymphoma, astrocytoma and breast cancer. The main ingredient active of antineoplaston A10 (Phenylacetylglutamine, PG) inhibits RAS and promotes apoptosis.
More Information Supplier PageA unique collection of 817 compounds used for exploring the relationship between anti-oxidation and some diseases such as aging,cancer,alzheimer’s disease,parkinson’s disease,diabetes,etc.
More Information Supplier PageAntipyrine (Phenazone,Phenazon) is an analgesic and antipyretic agent; selective COX-3 inhibitor.
More Information Supplier PageA unique collection of 757 antiviral compounds used for exploring novel antiviral drug.
More Information Supplier PageAntrodia Cinnamomea Extract is extracted from Antrodia Cinnamomea, which is a novel anticancer agent in tamoxifen-resistant breast cancer management.
More Information Supplier PageAnwuligan (Macelignan), a natural compound isolated from Myristica fragrans Houtt, has antimicrobial and anticariogenic activity against Streptococcus mutans and other streptococcus species. It also shows antioxidant, free radical scavenging, and neuroprotective activities.
More Information Supplier PageAOA (Aminooxyacetic acid) hemihydrochloride is an inhibitor of aminobutyrate aminotransferase involved in amino acid and polyamine metabolism. AOA hemihydrochloride is also a CBS (cystathionine β-synthase) inhibitor.
More Information Supplier PageAOA (Aminooxyacetic acid) hemihydrochloride is an inhibitor of aminobutyrate aminotransferase involved in amino acid and polyamine metabolism. AOA hemihydrochloride is also a CBS (cystathionine β-synthase) inhibitor.
More Information Supplier PageAOA (Aminooxyacetic acid) hemihydrochloride is an inhibitor of aminobutyrate aminotransferase involved in amino acid and polyamine metabolism. AOA hemihydrochloride is also a CBS (cystathionine β-synthase) inhibitor.
More Information Supplier PageAOH1996 is an orally active small-molecule PCNA inhibitor with potential anti-tumor activity. It enhances the interaction between PCNA and RPB1, the largest subunit of RNA polymerase II.
More Information Supplier PageAOH1996 is an orally active small-molecule PCNA inhibitor with potential anti-tumor activity. It enhances the interaction between PCNA and RPB1, the largest subunit of RNA polymerase II.
More Information Supplier PageAOH1996 is an orally active small-molecule PCNA inhibitor with potential anti-tumor activity. It enhances the interaction between PCNA and RPB1, the largest subunit of RNA polymerase II.
More Information Supplier PageAOH1996 is an orally active small-molecule PCNA inhibitor with potential anti-tumor activity. It enhances the interaction between PCNA and RPB1, the largest subunit of RNA polymerase II.
More Information Supplier PageAP-III-a4 (ENOblock) is the first nonsubstrate analogue inhibitor of enolase with IC50 of 0.576 μM.
More Information Supplier PageAP-III-a4 (ENOblock) is the first nonsubstrate analogue inhibitor of enolase with IC50 of 0.576 μM.
More Information Supplier Page
